Skip to main navigation
Skip to main content
Skip to Footer

English
- Français

Canada
- Sandoz Site Directory

Our Work
About Us
Products
News
Careers

Search

All News

Advanced Search Basic Search

From Date:

To Date:

Show:

All

Media Releases

Filter By

2021

May

Media Release / May 12, 2021

A first in Canada: generic version of pirfenidone

Story / May 12, 2021

A first in Canada: generic version of pirfenidone

Pirfenidone is indicated in the treatment for idiopathic pulmonary fibrosis in adults.

April

Story / Apr 30, 2021

Winner at Les Mercuriades

Sandoz Canada is proud to be the winner of two categories this year.

Media Release / Apr 27, 2021

Novartis Q1 2021 Financial Results

Story / Apr 21, 2021

New biosimilar switch policy in New Brunswick improves patient access to safe and effective medicines

Media Release / Apr 21, 2021

New biosimilar switch policy in New Brunswick improves patient access to safe and effective medicines

Story / Apr 13, 2021

Third consecutive recognition for Novartis in Canada as a Great Place to Work®

Media Release / Apr 09, 2021

Finalist at Les Mercuriades

February

Media Release / Feb 16, 2021

Sandoz Canada completes its 5th biosimilar launch with new biosimilar Hyrimoz® (adalimumab)

Story / Feb 16, 2021

Sandoz Canada completes its 5th biosimilar launch with new biosimilar Hyrimoz® (adalimumab)

Search Results Navigation

Current page 1 of 5
Page 2 of 5
Page 3 of 5
Page 4 of 5
Page 5 of 5
…
Next page
Last page

- TwitterTweet
- FacebookShare
- Share
  - Twitter
  - Facebook
  - LinkedIn
  - Email
- Jump to Comments

You are here

Home ›

Sandoz Canada

Our Work
About Us
Products
News
Careers
Contact Us
Office Locations
Stay up to date

Subscribe to Sandoz

Facebook
Twitter
YouTube
LinkedIn
RSS

Sandoz Site Directory

© 2021 Sandoz AG

This site is intended for an audience in Canada

Terms of Use
Privacy Policy
Terms of Trade
Return Policy